Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen
NCT02191332
·
clinicaltrials.gov ↗
COMPLETED
Status
147
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Viramune
Sponsor
Boehringer Ingelheim